|
"yen cj"的相關文件
顯示項目 1-50 / 99 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-06-21 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study
|
Tsai, HJ;Yang, SH;Hsiao, CF;Kao, HF;Su, YY;Shan, YS;Yen, CJ;Du, JS;Hsu, C;Wu, IC;Chen, LT |
| 國家衛生研究院 |
2024-03-25 |
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer
|
Tang, CY;Yang, SH;Li, CP;Su, YY;Chiu, SC;Bai, LY;Shan, YS;Chen, LT;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chiang, NJ;Chou, WC |
| 國家衛生研究院 |
2024-02-13 |
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan
|
Cheng, SM;Su, YY;Chiang, NJ;Wang, CJ;Chao, YJ;Huang, CJ;Tsai, HJ;Chen, SH;Chang, CY;Tsai, CR;Li, YJ;Yen, CJ;Chuang, SC;Chang, JSM;Shan, YS;Hwang, DY;Chen, LT |
| 國家衛生研究院 |
2023-07-04 |
The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study
|
Yen, CC;Yang, YH;Ku, HY;Hu, HM;Lo, SS;Chang, HC;Chao, Y;Chen, JS;Wang, HP;Wang, TE;Bai, LY;Wu, MS;Yen, CJ;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2023-06-27 |
Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort study
|
Liu, YW;Lee, JY;Wang, YK;Chen, YH;Fang, PT;Chou, SH;Chen, MH;Bai, LY;Yen, CJ;Wu, MT;Wu, IC |
| 國家衛生研究院 |
2023-02-05 |
Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer
|
Su, YY;Chiang, NJ;Yang, YH;Yen, CJ;Bai, LY;Chiu, CF;Chuang, SC;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chan, DC;Peng, CM;Chiu, SC;Li, CP;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2023-02 |
ASO visual abstract: Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment
|
Lin, YH;Hsiao, JR;Wu, YH;Chang, JS;Ou, CY;Lee, WT;Huang, CC;Chang, CC;Lai, YH;Tsai, ST;Hsueh, WT;Yen, CJ;Lin, CL;Chen, YS;Jiang, SS;Su, YC;Wu, SY |
| 國家衛生研究院 |
2023-02 |
Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment
|
Lin, YH;Hsiao, JR;Wu, YH;Chang, JS;Ou, CY;Lee, WT;Huang, CC;Chang, CC;Lai, YH;Tsai, ST;Hsueh, WT;Yen, CJ;Lin, CL;Chen, YS;Jiang, SS;Su, YC;Wu, SY |
| 國家衛生研究院 |
2022-11-15 |
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma
|
Chiang, NJ;Shan, YS;Li, CP;Yang, SH;Su, YY;Chiu, SC;Bai, LY;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2022-09-15 |
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chen, YY;Hsueh, SW;Yang, SH;Chiu, SC;Chiang, NJ;Chiu, TJ;Li, CP;Bai, LY;Chiu, CF;Chuang, SC;Shan, YS;Chan, DCA;Chen, LT;Yen, CJ;Peng, CM;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2022-07 |
Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience
|
Ting, YL;Su, YY;Chiang, NJ;Chao, YJ;Li, YJ;Huang, CJ;Liao, TK;Su, PJ;Liu, IT;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-06-22 |
Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study
|
Su, YY;Chiang, NJ;Li, CP;Yen, CJ;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chuang, SC;Bai, LY;Chiu, CF;Peng, CM;Chan, DC;Chiu, SC;Yang, YH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-05-15 |
Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience
|
Su, YY;Ting, YL;Wang, CJ;Chao, YJ;Liao, TK;Su, PJ;Chiang, NJ;Liao, IC;Yu, YT;Liu, YS;Tsai, HM;Li, YJ;Huang, CJ;Liu, IT;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-04-15 |
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan
|
Yang, SH;Chiang, NJ;Chiu, SC;Chou, WC;Bai, LY;Li, CP;Su, YY;Chiu, TJ;Chuang, SC;Peng, CM;Chan, DC;Chen, JS;Yen, CJ;Chen, YY;Chiu, CF;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2022-02-19 |
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chiu, TJ;Yang, SH;Chiu, SC;Hsueh, SW;Chiang, NJ;Li, CP;Bai, LY;Cheng, FM;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Su, YY;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2021-11-20 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2021-11-12 |
The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience
|
Tsai, HJ;Hsiao, CF;Chang, JS;Chen, LT;Chao, YJ;Yen, CJ;Shan, YS |
| 國家衛生研究院 |
2021-07-15 |
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
|
Shan, YS;Chen, LT;Wu, CH;Chang, YF;Lee, CT;Chiang, NJ;Chao, YJ;Yen, CJ;Tsai, HJ;Huang, HE;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
|
Chang, KY;Chiang, NJ;Wu, SY;Yen, CJ;Chen, SH;Yeh, YM;Li, CF;Feng, XX;Wu, K;Johnston, A;Bomalaski, JS;Wu, BW;Gao, JJ;Subudhi, SK;Kaseb, AO;Blando, JM;Yadav, SS;Szlosarek, PW;Chen, LT |
| 國家衛生研究院 |
2021-05-04 |
Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
|
Huang, CC;Su, YC;Chang, CC;Lee, WT;Ou, CY;Wu, YH;Wu, SY;Lai, YH;Huang, JS;Chen, KC;Hsueh, WT;Tsai, ST;Yen, CJ;Chang, JY;Tsai, ML;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Hsiao, JR;Chang, JS |
| 國家衛生研究院 |
2021-01-21 |
Metformin resensitizes sorafenib-resistant HCC cells through AMPK-dependent autophagy activation
|
Lai, HY;Tsai, HH;Yen, CJ;Hung, LY;Yang, CC;Ho, CH;Liang, HY;Chen, FW;Li, CF;Wang, JM |
| 國家衛生研究院 |
2021-01 |
Metformin resensitizes sorafenib-resistant HCC cells through AMPK-dependent autophagy activation
|
Lai, HY;Tsai, HH;Yen, CJ;Hung, LY;Yang, CC;Ho, CH;Liang, HY;Chen, FW;Li, CF;Wang, JM |
| 中山醫學大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study
|
Chiu, TJ; Su, YY; Yang, SH; Li, CP; Bai, LY; Chiang, NJ; Chuang, SC; Shan, YS; Chan, DC; Chen, LT; Yen, CJ; Peng, CM; Chen, YY; Chen, JS; Chou, WC |
| 國家衛生研究院 |
2020-11-27 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors
|
Shiah, HS;Chiang, NJ;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Wang, CC;Chang, JY;Chen, LT |
| 國家衛生研究院 |
2020-11-13 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-08 |
Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer
|
Hsiao, JR;Huang, CC;Ou, CY;Chang, CC;Lee, WT;Tsai, ST;Huang, JS;Chen, KC;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2020-05-28 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, NJ;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Su, YY;Chen, JS;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-05-26 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, YS;Chen, LT;Wu, JS;Chang, YF;Lee, CT;Wu, CH;Chiang, NJ;Huang, HE;Yen, CJ;Chao, YJ;Tsai, HJ;Chen, CY;Kang, JW;Kuo, CF;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2020-05-04 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-04 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono, J;Lin, CC;Chen, LT;Corral, J;Michalarea, V;Rihawi, K;Ong, M;Lee, JH;Hsu, CH;Yang, JC;Shiah, HS;Yen, CJ;Anthoney, A;Jove, M;Buschke, S;Fuertig, R;Schmid, U;Goeldner, RG;Strelkowa, N;Huang, DC;Bogenrieder, T;Twelves, C;Cheng, AL |
| 國家衛生研究院 |
2020-03-10 |
Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma
|
Liao, WY;Hsu, CC;Chan, TS;Yen, CJ;Chen, WY;Pan, HW;Tsai, KK |
| 國家衛生研究院 |
2020-03-01 |
A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis
|
Lai, CH;Chen, RY;Hsieh, HP;Tsai, SJ;Chang, KC;Yen, CJ;Huang, YC;Liu, YW;Lee, JC;Lai, YC;Hung, LY;Lin, BW |
| 國家衛生研究院 |
2020-03 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY |
| 中山醫學大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, JS; Hsieh, RK; Chen, JS; Lee, KD; Rau, KM; Shao, YY; Sung, YC; Yeh, SP; Chang, CS; Liu, TC; Wu, MF; Lee, MY; Yu, MS; Yen, CJ; Lai, PY; Hwang, WL; Chiou, TJ |
| 國家衛生研究院 |
2019-10-05 |
Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors
|
Su, YY;Liu, YS;Chao, YJ;Chiang, NJ;Yen, CJ;Tsai, HM |
| 國家衛生研究院 |
2019-04-12 |
Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer
|
Hsiao, JR;Lee, WT;Ou, CY;Huang, CC;Chang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2019-04 |
Oral hygiene and the overall survival of head and neck cancer patients
|
Chang, CC;Lee, WT;Hsiao, JR;Ou, CY;Huang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2019-01-12 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
|
Yen, CJ;Tsou, HH;Hsieh, CY;Chu, CY;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY;Chang, KY |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2018-10-01 |
The influence of pre-diagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients
|
Lee, WT;Hsiao, JR;Ou, CY;Huang, CC;Chang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 臺大學術典藏 |
2018-09-10T08:06:10Z |
Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults
|
Hwang, JJ;Lin, LY;Hwang, Juey-Jen;Lin, Lian-Yu;Yu, YH;Yu, Yau-Hua;Chang, CC;Chang, Chien-Cheng;Chang, KJ;HON-MAN LIU;Chang, King-Jen;Yen, CJ;Yen, Chung-Jen;LIAN-YU LIN;Liu, HM;CHUNG-JEN YEN;CY;Liu, Hon-Man;Chen, Ching-Yu;JUEY-JEN HWANG;Chen;Kuo, Hsu-Ko;Kuo, HK;CHING-YU CHEN;Hwang, J.-J.;Lin, L.-Y.;Yu, Y.-H.;Chang, C.-C.;Chang, K.-J.;Yen, C.-J.;Liu, H.-M.;Chen, C.-Y.;Kuo, H.-K.; Kuo, H.-K.; Chen, C.-Y.; Liu, H.-M.; Yen, C.-J.; Chang, K.-J.; Chang, C.-C.; Yu, Y.-H.; Lin, L.-Y.; Hwang, J.-J.; CHING-YU CHEN; Kuo, HK; Kuo, Hsu-Ko; Chen; JUEY-JEN HWANG; Chen, Ching-Yu; Liu, Hon-Man; CY; CHUNG-JEN YEN; Liu, HM; LIAN-YU LIN; Yen, Chung-Jen; Yen, CJ; Chang, King-Jen; HON-MAN LIU; Chang, KJ; Chang, Chien-Cheng; Chang, CC; Yu, Yau-Hua; Yu, YH; Lin, Lian-Yu; Hwang, Juey-Jen; Lin, LY; Hwang, JJ |
| 國家衛生研究院 |
2018-06 |
The interplay between oral microbiome, lifestyle factors, and genetic polymorphisms in the risk of oral squamous cell carcinoma
|
Hsiao, JR;Chang, CC;Lee, WT;Huang, CC;Ou, CY;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2018-05 |
A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers
|
Chang, KY;Chiang, NJ;Yen, CJ;Wu, SY;Chen, SH;Johnston, A;Bomalaski, JS;Wu, BW;Chen, LT |
| 國家衛生研究院 |
2018-04-05 |
ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2017-10-24 |
Investigating the association between diet and risk of head and neck cancer in Taiwan
|
Chang, CC;Lee, WT;Lee, YC;Huang, CC;Ou, CY;Lin, YH;Huang, JS;Wong, TY;Chen, KC;Hsiao, JR;Lu, YC;Tsai, ST;Lai, YH;Wu, YH;Hsueh, WT;Yen, CJ;Wu, SY;Chang, JY;Fang, SY;Wu, JL;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2017-08-29 |
Investigating the association between alcohol and risk of head and neck cancer in Taiwan
|
Huang, CC;Hsiao, JR;Lee, WT;Lee, YC;Ou, CY;Chang, CC;Lu, YC;Huang, JS;Wong, TY;Chen, KC;Tsai, ST;Fang, SY;Wu, JL;Wu, YH;Hsueh, WT;Yen, CJ;Wu, SY;Chang, JY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2017-06-15 |
Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress
|
Wu, CY;Hsu, WL;Tsai, MH;Liang, JL;Lu, JH;Yen, CJ;Yu, HS;Noda, M;Lu, CY;Chen, CH;Yan, SJ;Yoshioka, T |
| 國家衛生研究院 |
2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy
|
Chiang, NJ;Shiah, HS;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Chen, LT |
| 國家衛生研究院 |
2017-04-21 |
Regular recreational physical activity and risk of head and neck cancer
|
Lin, CL;Lee, WT;Ou, CY;Hsiao, JR;Huang, CC;Huang, JS;Wong, TY;Chen, KC;Tsai, ST;Fang, SY;Huang, TT;Wu, JL;Wu, YH;Hsueh, WT;Yen, CJ;Lai, YH;Liao, HC;Wu, SY;Yang, MW;Lin, FC;Chang, JY;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT |
顯示項目 1-50 / 99 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
